Information Provided By: 
Fly News Breaks for November 26, 2019
SPLK
Nov 26, 2019 | 06:18 EDT
JMP Securities analyst Erik Suppiger raised his price target on Splunk to $155 and kept his Outperform rating after its Q3 earnings beat and a 28% increase in billings along with its FY20 guidance range. The analyst maintains his view that Splunk is undervalued, currently trading at an enterprise value to expected 2021 revenue multiple of 6.2-times.
News For SPLK From the Last 2 Days
SPLK
Apr 23, 2024 | 08:31 EDT
New option listings for April 23rd include Express Inc (EXPRQ). Option delistings effective April 23rd include PGT Innovations Inc (PGTI), NGM Biopharmaceuticals Inc (NGM), Karuna Therapeutics Inc (KRTX), KINNATE BIOPHARMA INC (KNTE), Daseke Inc (DSKE), Tritium Dcfc Ltd (DCFC), Xtrackers MSCI All China Equity ETF (CN), CymaBay Therapeutics Inc (CBAY), Alteryx Inc (AYX), XTRACKERS MSCI CHINA A INCLUSION EQUITY ETF (ASHX), Recro Pharma, Inc. (SCTL), Splunk Inc (SPLK), and Textainer Group Holdings Limited (TGH).
